申请人:Edwards Louise
公开号:US20120302596A1
公开(公告)日:2012-11-29
Described herein are compounds with affinity for the 5-HT
6
receptor, which have the general formula I:
wherein A, B, D, E, R
1
to R
3
and n are described herein. Also described is the use of these compounds as pharmaceuticals to treat indications where inhibition of the 5-HT
6
receptor is implicated, such as schizophrenia.
本文介绍了具有亲和力的化合物,其与5-HT6受体具有亲和力,其通式为I:其中A、B、D、E、R1至R3和n的描述如本文所述。还描述了这些化合物作为药物用于治疗抑制5-HT6受体有所涉及的适应症,例如精神分裂症。